Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps

被引:4
|
作者
Ramkumar, Shreya P. [1 ,2 ]
Lal, Devyani [1 ]
Miglani, Amar [1 ]
机构
[1] Mayo Clin Hosp, Dept Otolaryngol Head & Neck Surg, Phoenix, AZ USA
[2] St Louis Univ, Sch Med, St Louis, MO USA
来源
FRONTIERS IN ALLERGY | 2023年 / 4卷
关键词
chronic rhinosinusitis (CRS); shared decision making; biologics; nasal polyps (NP); treatment; ENDOSCOPIC SINUS SURGERY; IN-OFFICE TREATMENT; ADULT CHRONIC RHINOSINUSITIS; HEALTH OUTCOMES; ADHERENCE; IMPLANTS; BARRIERS; EFFICACY; CORTICOSTEROIDS; COMPLICATIONS;
D O I
10.3389/falgy.2023.1137907
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Shared decision-making is an approach where physicians and patients work together to determine a personalized treatment course. Such an approach is integral to patient-centered care in chronic rhinosinusitis with nasal polyps (CRSwNP). CRSwNP is a chronic inflammatory condition of the sinonasal cavity that can severely impact physical health, smell, and quality of life (QOL). Traditional standard-of-care treatment options include topical (i.e. sprays) and oral corticosteroids and endoscopic sinus surgery, but more recently, novel corticosteroid delivery methods (i.e. high volume irrigations, recently-approved exhalation breath-powered delivering devices, and drug-eluting steroid implants) and 3 new FDA approved biologics directed against type II immunomodulators have become available. The availability of these therapeutics offers exciting new opportunities in CRSwNP management but requires personalized and shared-decision making as each modality has variable impacts on CRSwNP and related comorbid conditions. Studies have published treatment algorithms, but the practical use of these lean guidelines is heavily influenced by the lens of the treating physician, the most common being otolaryngologists and allergy immunologists. Clinical equipoise occurs when there is no basis for one intervention to be regarded as "better" than another. While most guidelines, in general, support the use of topical corticosteroids with or without oral corticosteroids followed by ESS for the majority of unoperated CRSwNP patients, there are situations of clinical equipoise that arise particularly in CRSwNP who have failed surgery or those with severe comorbid conditions. In the shared decision-making process, clinicians and patients must consider symptomatology, goals, comfort, compliance, treatment efficacy, and treatment cost when determining the initial choice of therapy and escalation of therapy with the potential use of multiple modalities for recalcitrant CRSwNP. A summary of salient considerations that might constitute shared decision-making is presented in this summary.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The microbiology of chronic rhinosinusitis with and without nasal polyps
    Liu, Qinghua
    Lu, Xinxin
    Bo, Mingyu
    Qing, Hui
    Wang, Xiangdong
    Zhang, Luo
    ACTA OTO-LARYNGOLOGICA, 2014, 134 (12) : 1251 - 1258
  • [42] Biological therapy in chronic rhinosinusitis with nasal polyps
    Jin, Zeyi
    Yan, Bing
    Zhang, Luo
    Wang, Chengshuo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2025,
  • [43] Chronic rhinosinusitis with nasal polyps: changing expectations
    Piltcher, Otavio B.
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2024, 90 (02)
  • [44] Treatable traits in chronic rhinosinusitis with nasal polyps
    Heffler, Enrico
    Malvezzi, Luca
    Pirola, Francesca
    Zieba, Natalia
    Paoletti, Giovanni
    Mercante, Giuseppe
    Spriano, Giuseppe
    Canonica, Giorgio Walter
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (04) : 373 - 378
  • [45] Corticosteroid Treatment Regulates Mucosal Remodeling in Chronic Rhinosinusitis With Nasal Polyps
    de Borja Callejas, Francisco
    Martinez-Anton, Asuncion
    Picado, Cesar
    Alobid, Isam
    Pujols, Laura
    Valero, Antonio
    Roca-Ferrer, Jordi
    Mullol, Joaquim
    LARYNGOSCOPE, 2015, 125 (05): : E158 - E167
  • [46] The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps
    Bachert, Claus
    Desrosiers, Martin Y.
    Hellings, Peter W.
    Laidlaw, Tanya M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1099 - 1106
  • [47] The role of macrolides in chronic rhinosinusitis and nasal polyps
    Suzaki, Isao
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 25 (01) : 19 - 26
  • [48] Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps
    Bachert, Claus
    Gevaert, Philippe
    Hellings, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1512 - 1516
  • [49] Budesonide therapy for chronic rhinosinusitis with nasal polyps
    Kessing, Richard
    LARYNGO-RHINO-OTOLOGIE, 2024, 103 (11) : 769 - 770
  • [50] Outcome measures for chronic rhinosinusitis with nasal polyps
    Sedaghat, Ahmad R.
    Campbell, Raewyn G.
    Douglas, Richard G.
    Fokkens, Wytske J.
    Hamizan, Aneeza W.
    Korban, Zeina R.
    Lee, Victoria S.
    Macias-Valle, Luis
    Romano, Fabrizio R.
    Snidvongs, Kornkiat
    Alsaleh, Saad
    RHINOLOGY, 2024, 62 : 1 - 31